Physical performance and glycemic control under SGLT-2-inhibitors in patients with type 2 diabetes and established atherosclerotic cardiovascular diseases or high cardiovascular risk (PUSH): Design…

Overview of attention for article published in Frontiers in Cardiovascular Medicine, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,608 followers.

RT @BernCVRC: New publication: “Physical performance and glycemic control under SGLT-2-inhibitors in patients with T2D and established athe…

07 Sep 2022

Reply Repost Favourite

New publication: “Physical performance and glycemic control under SGLT-2-inhibitors in patients with T2D and established atherosclerotic cardiovascular diseases or high cardiovascular risk (PUSH)”. Congratulations to the authors! https://t.co/juKrItkq0V @M

07 Sep 2022

Reply Repost Favourite

New Research: Physical performance and glycemic control under SGLT-2-inhibitors in patients with type 2 diabetes and established atherosclerotic cardiovascular diseases or high cardiovascular risk (PUSH): Design of a 4-week prospective… https://t.co/PoJrLo

23 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.